Mary L. Smith

Insider Reports History

Entity
Individual
Location
C/O Ptc Therapeutics, Inc., 100 Corporate Court, South Plainfield, NJ
Signature
/s/ Avraham S. Adler, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mary L. Smith:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PTC THERAPEUTICS, INC. Director Common Stock 13.8K $376K $27.25 Feb 15, 2024 Direct
PTC THERAPEUTICS, INC. Director Stock Option (Right to Buy) 10K $271K $27.05 Feb 15, 2024 Direct

Insider Reports Filed by Mary L. Smith

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PTCT PTC THERAPEUTICS, INC. Feb 15, 2024 2 $0 4 Feb 16, 2024 Director
PTCT PTC THERAPEUTICS, INC. Jan 5, 2023 2 $0 4 Jan 9, 2023 Director
PTCT PTC THERAPEUTICS, INC. Jan 7, 2022 2 $0 4 Jan 11, 2022 Director
PTCT PTC THERAPEUTICS, INC. Jun 11, 2021 4 $0 4 Jun 15, 2021 Director
PTCT PTC THERAPEUTICS, INC. Jun 8, 2021 0 $0 3 Jun 15, 2021 Director